Prime Medicine, Inc. Annual Return On Equity in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Prime Medicine, Inc. quarterly/annual Return On Equity history and growth rate from 2021 to 2023.
  • Prime Medicine, Inc. Return On Equity for the quarter ending September 30, 2024 was -115 %, a 72.2% decline year-over-year.
  • Prime Medicine, Inc. annual Return On Equity for 2023 was -93.7 %, a 152% decline from 2022.
  • Prime Medicine, Inc. annual Return On Equity for 2022 was 181 %, a 13.5% increase from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -93.7 -275 -152% Jan 1, 2023 Dec 31, 2023
2022 181 +21.6 +13.5% Jan 1, 2022 Dec 31, 2022
2021 160 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.